title: Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy.
abstract: BACKGROUND
  Deposition of uric acid in the kidney can lead to progressive tubulointerstitial injury with granuloma formation. We hypothesized that uric acid crystal deposition may induce granuloma formation by stimulating local expression of macrophage migration inhibitory factor (MIF), which is a known mediator of delayed type hypersensitivity (DTH).
  
  
  METHODS
  A model of acute uric acid nephropathy was induced in rats by the administration of oxonic acid (an inhibitor of uricase), together with uric acid supplements. MIF expression and local cellular response were examined by in situ hybridization and immunohistochemistry.
  
  
  RESULTS
  Kidney tissue examined at 35 days posttreatment showed widespread tubulointerstitial damage with intratubular uric acid crystal deposition and granuloma formation. Tubules within the areas of granuloma showed a six-fold increase in MIF mRNA, compared with uninvolved areas by in situ hybridization. Moreover, the areas of increased MIF mRNA expression correlated with sites of dense accumulation of macrophages and T cells, and these cells were activated when assessed by the expression of interleukin-2R (IL-2R) and (MHC) class II. Interestingly, cytoplasmic staining for MIF protein in the uric acid (UA) crystal-associated granulomatous lesions was reduced, indicating a rapid MIF secretion by damaged tubules and macrophages secondary to uric acid crystal stimulation. This was confirmed by the demonstration of a marked increase in urinary MIF protein by Western blot analysis. Control rats fed either a normal diet or only oxonic acid had no discernible evidence of renal disease by routine light microscopy and minimal tubular expression of MIF mRNA and protein.
  
  
  CONCLUSIONS
  These data suggest that intrarenal granulomas in urate nephropathy may be the consequence of a crystal induced DTH reaction mediated by MIF.
authors: Division of Nephrology, University of Washington Medical Center, Seattle, USA.
authors: Y G
authors: YG
authors: Kim
authors: X R
authors: XR
authors: Huang
authors: S
authors: S
authors: Suga
authors: M
authors: M
authors: Mazzali
authors: D
authors: D
authors: Tang
authors: C
authors: C
authors: Metz
authors: R
authors: R
authors: Bucala
authors: S
authors: S
authors: Kivlighn
authors: R J
authors: RJ
authors: Johnson
authors: H Y
authors: HY
authors: Lan
mesh_terms: D000818:Animals; D007150:Immunohistochemistry; D007674:Kidney Diseases / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology; D007677:Kidney Function Tests; D008263:Macrophage Migration-Inhibitory Factors / Q000235:genetics / Q000502:physiology*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D015854:Up-Regulation; D014527:Uric Acid / Q000097:blood / Q000633:toxicity*
chemical_list: D008263:Macrophage Migration-Inhibitory Factors; D014527:Uric Acid